A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 15,168 shares of NRIX stock, worth $300,781. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,168
Previous 15,168 -0.0%
Holding current value
$300,781
Previous $340,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$18.93 - $25.69 $738 - $1,001
-39 Reduced 0.26%
15,168 $340,000
Q2 2024

Jul 29, 2024

BUY
$12.02 - $21.3 $161,596 - $286,357
13,444 Added 762.56%
15,207 $317,000
Q1 2024

Apr 25, 2024

BUY
$7.77 - $15.66 $13,698 - $27,608
1,763 New
1,763 $25,000
Q3 2023

Oct 25, 2023

SELL
$7.86 - $10.08 $7 - $10
-1 Reduced 0.02%
5,482 $43,000
Q1 2023

May 08, 2023

SELL
$8.56 - $13.26 $7,096 - $10,992
-829 Reduced 13.13%
5,483 $48,000
Q4 2022

Feb 01, 2023

BUY
$9.86 - $14.59 $11,772 - $17,420
1,194 Added 23.33%
6,312 $69,000
Q1 2022

Apr 21, 2022

BUY
$12.94 - $29.65 $13,858 - $31,755
1,071 Added 26.46%
5,118 $72,000
Q4 2021

Feb 01, 2022

BUY
$26.43 - $34.5 $106,962 - $139,621
4,047 New
4,047 $117,000

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $935M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.